Results 81 to 90 of about 316,189 (194)

Microangiopathy in diabetic polyneuropathy revisited.

open access: yesEuropean review for medical and pharmacological sciences, 2018
Microangiopathy is a major cause in diabetic polyneuropathy (DPN). This review examines evidence from both human and animal studies to elucidate the important microvascular factors in DPN.This is a literature review of articles published on PubMed in English.There is an abundance of evidence linking endoneurial microvascular abnormalities to peripheral
Fang, F.   +3 more
openaire   +2 more sources

The indicators of stimulation electroneuromyography in patients with diabetic polyneuropathy

open access: yes, 2017
The work is dedicated to researching of the effect of cocarnit on the functional state of the peripheral nerves based on the findings of stimulation electroneuromyography in multimodality treatment of diabetic polyneuropathy.
Pavlovych, L.B., Bilous, I.I.
core  

Diabetic foot disease and oedema [PDF]

open access: yes, 2013
Diabetic foot ulcers (DFUs) are common and disabling, giving rise to significant morbidity and mortality as well as worldwide socioeconomic problems. Despite treatment, DFUs readily become chronic wounds and may lead to major lower limb amputations.
Leigh, RD, Tsui, J, Ho, TK
core  

Bridging gaps in diabetic neuropathy care: A Delphi‐based regional consensus from the Gulf Cooperation Council

open access: yesJournal of Diabetes Investigation, EarlyView.
A three‐round Delphi consensus developed GCC‐specific, evidence‐based recommendations for diabetic peripheral neuropathy (DPN) and painful diabetic neuropathy (PND). The consensus emphasizes proactive screening, early multimodal management, and addressing regional barriers to improve early detection, optimize management, and enhance quality of life ...
Abdulrahman Alshaikh   +13 more
wiley   +1 more source

Blink reflex alterations in diabetic patients with or without polyneuropathy

open access: yes, 2008
The main aim of this study is to evaluate the role of blink reflex for early diagnosis of cranial neuropathy in diabetic patients with or without polneuropathy.
Guney, Figen   +2 more
core   +1 more source

SGLT2i use and fracture risk compared with DPP4i in patients with T2DM

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Introduction The association between sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) use and fracture risk remains inconclusive. Most previous studies have focused on treatment‐naïve patients, despite many patients in routine clinical practice initiating SGLT2i therapy after prior dipeptidyl peptidase‐4 inhibitor (DPP4i) use.
Sung‐Yen Lin   +5 more
wiley   +1 more source

Cocarnit in the multimodality treatment of diabetic polyneuropathy

open access: yes, 2016
The work is dedicated to researching of the effect of cocarnit on the functional state of the peripheral nerves based on the findings of stimulation electroneuromyography in multimodality treatment of diabetic polyneuropathy.
Bilous, I.I.   +2 more
core  

The sensitivity of electromyoneurography in the diagnosis of diabetic polyneuropathy

open access: yes, 2011
Diabetic polyneuropathy is a complex set of clinical syndromes, which deplete various regions of the nervous system. The process leading to diabetic neuropathy is multi-factorial. Its symptoms are paresthesia, dysesthesia and pain.
Miroslav Ilin   +4 more
core   +1 more source

Combined nerve conduction index in diabetic polyneuropathy [PDF]

open access: yes, 2012
Diabetic polyneuropathy can be confirmed by nerve conduction studies. The data can be analyzed in the form of a combined index instead of individual parameters.
Flavia Costa Nunes Machado   +3 more
core   +1 more source

The dynamics of the parameter of lipid peroxidation, the oxidative modification of proteins and the of the blood antioxidant system 3 and 6 months after treating diabetic polyneuropathy

open access: yes, 2016
The authors have studied the effect of mildronat and thiotriazolin on the processes of lipid peroxidation, the oxidative modification of proteins and the state of the blood antioxidant system 3 and 6 months following a course of multimodality treatment ...
Bilous, I.I.   +3 more
core  

Home - About - Disclaimer - Privacy